Lowette®, a contraceptive for treating acne of young woman;Le médicament du mois: Lowette®, un contraceptif pour traiter l'acne♂ de la jeune femme

Revue Medicale de Liege

Volumn 58, Issue 4, 2003, Pages 261-263

  Goffin, V ^a   Pierard Franchimont C ^a   Pierard G E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Acne; Contraception

Indexed keywords

ANTI ACNE AGENT; CONTRACEPTIVE AGENT; ETHINYLESTRADIOL; LEVONORGESTREL; LOWETTE;

ACNE; ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; CONTRACEPTION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; HUMAN; INFLAMMATION; META ANALYSIS; PATIENT COMPLIANCE; REVIEW;

ACNE VULGARIS; CONTRACEPTIVES, ORAL, SYNTHETIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL CONGENERS; ETHINYL ESTRADIOL; FEMALE; HUMANS; LEVONORGESTREL;

EID: 0041428229     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Piérard GE. - Quelles sont la définition et la pathogénie de l'acné? in Acné en 25 questions. Ed. par H. Degreef, J.M. Lachapelle, G.E. Piérard. Publ. Galderma Belgilux, 1999, 15-24.
2. Toyoda M, Morohashi M. - Pathogenesis of acne. Med Electron Microsc, 2001, 34, 29-40.
3. Cibula D, Hill M, Vohradnikova O, et al. - The role of androgens in determining acne severity in adult women. Br J Dermatol, 2000, 143, 399-404.
4. Thiboutot D, Chen WC. - Update and future of hormonal therapy in acne. Dermatology, 2003, 206, 57-67.
5. Palatsi R, Hirvensalo E, Liukko P, et al. - Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives. Acta Derm venereol, 1984, 64, 517-523.
6. Mango D, Ricci S, Manna P, et al. - Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris. Contraception, 1996, 53, 163-170.
7. Lemay A, Poulin Y. - Oral contraceptives as anti-androgenic treatment of acne. J Obstet Gynaecol Can, 2002, 24, 559-567.
8. Thiboutot D, Gilliland K, Light J, Lookingbill D. Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol, 1999, 135, 1041-1045.
9. Lucky AW, Henderson TA, Olson WH, et al. - Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol, 1997, 37, 746-754.
10. Redmond GP, Olson WH, Lippman JS, et al. - Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol, 1997, 89, 615-622.
11. Thiboutot D, Archer D, Lemay A, et al. - A randomized, controlled trial of a low dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment. Fertil Steril, 2001, 76, 461-468.
12. Leyden J, Shalita A, Hordinsky M, et al. - Efficacy of a low-dose oral contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for the treatment of moderate acne: a randomized, placebo-controlled trial. J Am Acad Dermatol, 2002, 47, 399-409.
13. Olson WH, Lippman JS, Robisch DM. - The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris. Int J Fertil Wom Med, 1998, 43, 286-290.
14. Piérard-Franchimont C, Gaspard V, Lacante P, et al. - A quantitative biometrological assessment of acne and hormonal evaluation in young women using a triphasic low-dose oral contraceptive containing gestodene. Eur J Contracept Reprod Health Care, 2000, 5, 275-286.
15. Piérard-Franchimont C, Goffin V, Arrese JE, et al. Lymecycline and minocycline in inflammatory acne. A randomized, double-blind study on clinical and in vivo antibacterial efficacy. Skin Pharmacol Appl Skin Physiol, 2002, 15, 112-119.
16. Uhoda E, Piérard-Franchimont C, Piérard GE. - Comedolysis by α lipohydroxyacid formulation in acne prone subjects. Eur J Dematol, 2003, 13, 65-68.
17. Thorneycroft IH, Stanczyk FZ, Bradshaw KD, et al. Effect of low-dose oral contraceptives on androgenic markers and acne. Contraception, 1999, 60, 255-262.
18. Archer DF, Maheux R, DelConte A, et al. - A new low-dose monophasic combination oral contraceptive (Alesse®) with levonorgestrel 100 μg and ethinyl estradiol 20 μg. Contraception, 1997, 55, 139-144.
19. Archer DF, Maheux R, DelConte A, et al. - Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®). Am J Obstet Gynecol, 1999, 181, S30-S44.
20. Coney P, Washenik K, Langley RGB, et al. - Weight change and adverse event incidence with a low-dose oral contraceptive: two randommized, placebo-controlled trials. Contraception, 2001, 63, 297-302.
21. Van Hooff MHA, Hirasing RA, Kaptein MBM, et al. The use of oral contraceptives by adolescents for contraception, menstrual cycle problems or acne. Acta Obstet Gynecol Scand, 1998, 77, 898-904.